Skip to content

13F-HR filed by Ally Bridge Group (NY) LLC

Ally Bridge Group (NY) LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:33:20 UTC, with 18 holding rows worth $76,049,458.

Accession
0001193125-26-463652
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 18 entries on the cover page, a total value of $76,049,458 stated on the cover page (in dollars after the unit check, H1), rows summing to $76,049,458 with VALUE read as dollars as filed, 13F file number 028-20834. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerFan Yu 028-20833

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DEFINIUM THERAPEUTICS INC24477V105COM SHS400,000$15,224,000dollars as filedcall
ABIVAX SA-00370M103SPONSORED ADS125,000$12,377,500dollars as filedcall
EDGEWISE THERAPEUTICS INC28036F105COM185,430$7,528,458dollars as filed
PROMIS NEUROSCIENCES INC74346M505COM SHS620,319$6,730,461dollars as filed
MINERVA NEUROSCIENCES INC603380205COM NEW1,655,500$5,545,925dollars as filed
AMYLYX PHARMACEUTICALS INC03237H101COM182,000$5,296,200dollars as filed
SHATTUCK LABS INC82024L103COMMON STOCK625,190$4,263,796dollars as filed
Obsidian Therapeutics, Inc.67448A106Common Stock, $0.0001 par value per share302,449$4,152,625dollars as filed
ALUMIS INC022307102COM400,000$2,956,000dollars as filedcall
AN2 THERAPEUTICS INC037326105COM526,315$2,799,996dollars as filed
EUPRAXIA PHARMACEUTICALS INC29842P105COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1231,122$2,103,210dollars as filed
COMPASS THERAPEUTICS INC20454B104COM2,000,000$2,080,000dollars as filedcall
AVALO THERAPEUTICS INC05338F306COMMON STOCK134,429$2,060,797dollars as filed
INVENTIVA SA46124U107ADS227,250$838,553dollars as filed
VOGENX INC92859A106COM32,701$745,256dollars as filed
TRAWS PHARMA INC68232V884COM NEW786,236$466,867dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK163,634$449,994dollars as filed
ASSEMBLY BIOSCIENCES INC045396207COMMON STOCK18,298$429,820dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-463652this filing2026-11-16